Antimicrobial resistance — a ‘rising tide’ of national (and international) risk

J. Cole^*
*Royal United Services Institute for Defence and Security Studies, UK
Journal of Hospital Infection (2016) 92, 3-4
No Abstract.
サマリー原文（英語）はこちら
監訳者コメント：
グローバルな視点に立って耐性菌の課題を突きつけている提言である。テロも怖いが耐性菌も深刻な問題であると指摘している。生命予後ならびに経済的損失についても推計値をもとに解説している。

Costs associated with COVID-19 in healthcare personnel in Greece: a cost-of-illness analysis

H.C. Maltezou*, T.V. Giannouchos, A. Pavli, P. Tsonou, X. Dedoukou, M. Tseroni, K. Papadima, D. Hatzigeorgiou, N.V. Sipsas, K. Souliotis
*National Public Health Organization, Greece

Journal of Hospital Infection (2021) 114, 126-133

Whole-genome sequencing analysis reveals the spread of a vanB-carrying transposon among different vancomycin-resistant Enterococcus faecium clinical isolates in a non-endemic setting

R.H.T. Nijhuis*, M.A. Chlebowicz-Fliss, A.E. Smilde, J.W.A. Rossen, A.J.L. Weersink, A.C.M. Gigengack-Baars

*Meander Medical Centre, The Netherlands

Journal of Hospital Infection (2021) 110, 52-59

Trends in mortality following Clostridium difficile infection in Scotland, 2010-2016: a retrospective cohort and case-control study

Reduction in chlorhexidine efficacy against multi-drug- resistant Acinetobacter baumannii international clone II

Risk factors for bacteraemia attributable to Pseudomonas aeruginosa resistant to imipenem, levofloxacin, or gentamicin